Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.

Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.

Item

http://www.wikidata.org/entity/Q39594851

Q39594851

about

Salinomycin as a drug for targeting human cancer stem cells Intracellular autofluorescence: a biomarker for epithelial cancer stem cells A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells Targeting lung cancer through inhibition of checkpoint kinases.DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.Mechanisms of chemoresistance in cancer stem cells.α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15 Pancreatic cancer stem cells: new insights and perspectives.Implication of cancer stem cells in cancer drug development and drug delivery.Cancer Stem Cells: A Moving Target The paradigm of mutant p53-expressing cancer stem cells and drug resistance.Cancer stem cells: are they responsible for treatment failure?Digital gene expression profiling analysis of DNA repair pathways in colon cancer stem population of HT29 cells.GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness.Therapeutic targeting of cancer stem cells.Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer Inactivation of PRIM1 Function Sensitizes Cancer Cells to ATR and CHK1 Inhibitors

P2860

Q21285139-488E4592-270F-4EA8-ACF7-25109885DDD0 Q28049473-FF1AFFFF-04B1-47B0-A54E-91111CEA556B Q28271944-F1846E06-976A-4038-9B7B-341575851199 Q28534130-48D5CF7D-B2FC-46E4-904D-B540A3A05DA6 Q35034700-85609918-4FE8-4EE8-ACD6-BAB7D2ADBAF8 Q35128547-1D1E4CF9-C89C-4EAF-832B-F79172D7D495 Q35941085-2E164588-1927-4358-84C2-3370AFC6D2AE Q35982489-68A0EBF4-46D5-4027-92C5-432EF28F138C Q36088183-22DD0451-7938-4DD0-A2C8-DE20E5E16A78 Q36165598-299999EA-EC73-4DE3-808B-1BEFC724AAB8 Q36591484-CEC2A8D2-EE0C-43C2-9AAB-935B41C80F9A Q36903223-60A6BF12-19E7-4488-B799-FC80E0699524 Q37893519-ECAE3319-AA36-4A45-AAF3-9C04187515C3 Q38034735-15ECA091-6AD8-49F9-A5D0-B3C634D225AA Q38126498-E1661B9F-993E-4EB6-98A5-93805EBD2D04 Q38198487-84ED79F6-1618-4601-B09A-271555D20333 Q38268164-B8686944-B41C-4D4B-BF38-054F45B9ACB3 Q38727052-29018453-AC39-448C-B605-74D615ECEC1B Q38727591-A47400D2-DD8F-494F-B5DA-33A4AFC676C0 Q38937280-110FA23D-E17B-4BAD-8C06-E8ECD6350909 Q39031410-B0680C49-BD9A-4243-9174-CEDE98235E3E Q39379114-C42268DC-EEF9-4929-9298-1DAE0B9B4B01 Q42175003-4BB1BC9C-2BBB-49F4-8076-5C4B05305194 Q58694941-8181233A-3A20-4B71-858E-61E92960284F Q58701948-2F297AAB-CD8D-4CB0-BEC6-FB5B8F5DAAFD

P2860

Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.

Item

http://www.wikidata.org/entity/Q39594851

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Inhibition of ataxia telangiec ...... through depletion of the CD133

@nl

Inhibition of ataxia telangiec ...... umor-initiating cell fraction.

@en

type

Item

label

Inhibition of ataxia telangiec ...... through depletion of the CD133

@nl

Inhibition of ataxia telangiec ...... umor-initiating cell fraction.

@en

prefLabel

Inhibition of ataxia telangiec ...... through depletion of the CD133

@nl

Inhibition of ataxia telangiec ...... umor-initiating cell fraction.

@en

P1476

Inhibition of ataxia telangiec ...... umor-initiating cell fraction.

@en

P2093

Andreas Palagyi

http://www.w3.org/2001/XMLSchema#string

Andreas Ziesch

http://www.w3.org/2001/XMLSchema#string

Belen Rubio-Viqueira

http://www.w3.org/2001/XMLSchema#string

Burkhard Göke

http://www.w3.org/2001/XMLSchema#string

Christian Eisen

http://www.w3.org/2001/XMLSchema#string

Christopher Heeschen

http://www.w3.org/2001/XMLSchema#string

Eike Gallmeier

http://www.w3.org/2001/XMLSchema#string

Enrico N De Toni

http://www.w3.org/2001/XMLSchema#string

Fred Bunz

http://www.w3.org/2001/XMLSchema#string

Joachim W Ellwart

http://www.w3.org/2001/XMLSchema#string

P2860

Caspases: pharmacological manipulation of cell death

Phenotypic characterization of human colorectal cancer stem cells

Structural basis for Chk1 inhibition by UCN-01

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Identification and expansion of human colon-cancer-initiating cells

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Stem cells, cancer, and cancer stem cells

The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01

A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome

Rapamycins: mechanism of action and cellular resistance

P304

418-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.595

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Hidalgo

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49824512

http://www.w3.org/2001/XMLSchema#string

P698

21308861

http://www.w3.org/2001/XMLSchema#string

Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.

about

P2860

P2860

Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698